The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Resources for Providers
Frequently Asked Questions (FAQs)
Professional Consultation Programs
Henry Ford Health System Hepatitis C Clinical Consult Program- a free consultation line is available Monday-Friday 8am-5pm for all health care professionals with questions about HCV disease management and treatment (313) 575-0332.
Midwest AIDS Training + Education Center (MATEC) Michigan - offers free HCV case-based office hours available for all health care professionals. To request an appointment with a physician specialized in HCV, please call (313) 962-2000. For urgent questions, including after hours and on weekends, call (313) 408-3483.
Michigan Opioid Collaborative HCV Virtual Case Conferencing - offers biweekly education and case consultation on hepatitis C to support primary care and community providers with diagnosis, treatment planning, and medication management of people living with hepatitis C. To learn more about this service, click here.
We Treat Hepatitis C: Focus on Michigan Medicaid Webinar
Join Dr. Cohn on his talk on treating Michigan Medicaid and Healthy Michigan Plan beneficiaries for their HCV infection.
Testing + Treatment
CDC Recommendations for Hepatitis C Testing
ACOG Routine Hepatitis C Virus Screening in Pregnant Individuals this practice advisory includes updated hepatitis C screening guidance to recommend screening for all pregnant individuals during each pregnancy during the first prenatal blood assessment.
MATEC + WSU Simplified Guidelines for Hepatitis C Treatment in Adults a step-by-step outline to managing HCV patients from testing, assessing liver status, ordering labs, prescribing and monitoring during treatment, to post-treatment evaluation.
AbbVie Quick Reference Guides for pre-treatment assessment, on-treatment monitoring, and post-treatment follow-up guide
AASLD + IDSA Hepatitis C Treatment Algorithm for Treatment-Naive Adults Without Cirrhosis
AASLD + IDSA Hepatitis C Treatment Algorithm for Treatment-Naive Adults With Compensated Cirrhosis
University of Liverpool - Hep Drug Interaction Checker tool for determining drug-drug interactions with hepatitis C medications
HCV in Adults Under 40 - fact sheet includes epidemiology of hepatitis C among adults under 40, testing recommendations, and information on the We Treat Hep C Initiative
We Treat Hepatitis C: Clinical Fact Sheet - clinical fact sheet summarizing hepatitis C, the We Treat Hep C Initiative, CDC hepatitis C testing recommendations, and provider trainings and resources
We Treat Hepatitis C: Patient Fact Sheet - patient fact sheet summarizing hepatitis C, the We Treat Hep C Initiative, CDC hepatitis C testing recommendations, hepatitis C treatment, and resources for the public
Michigan Medicaid Preferred Drug List
Medicaid L21-21 (April 6, 2021) - Removal of Prior Authorization for Hepatitis C Treatment
Standard Prior Authorization Form for Non-Preferred DAA required prior authorization form for HCV treatment using non-preferred DAA
Training + Resources
Michigan Opioid Collaborative - View the 3-Part Hepatitis C webinar series below:
- Part 1: Hepatitis C Screening and Epidemiology
- Part 2: Hepatitis C Treatment
- Part 3: Hepatitis C Post-Treatment and Key Topics for Consideration
Michigan Center for Rural Health - Project ECHO® model creating a community collaboration to assist providers and other members of the health care team throughout Northern Michigan and the Upper Peninsula more effectively and confidently manage their infectious disease patients. Each session accredited for 1 hour of CME. For more sessions visit the Project ECHO website.
- Hepatitis C for Primary Care - March 15, 2023 from 12 -1 PM Register
- Past Recording: Exploring the New Land of HCV Therapy